| Literature DB >> 27841342 |
Mei-Hua Jiang1, Chuan He2, Jian-Min Feng2, Zhi-Hui Li1, Zhe Chen1, Fu-Hua Yan1, Yong Lu1.
Abstract
To evaluate the efficacy of magnetic resonance imaging (MRI) parameter optimizations for the diagnosis of periprosthetic infection and tumor recurrence in joint replacement patients. We compared the quality of images for 16 joint replacement patients that were recorded using the optimized MRI parameters with and without view angle tilting (VAT) correction at 1.5 T in coronal fast-spin-echo T2-weighted MRI. The optimized MRI data of 86 patients with pain after hip replacement and 67 patients who received tumor resection and joint replacement for bone cancer were retrospectively analyzed to identify MRI features that were useful for the diagnosis of periprosthetic infection and tumor recurrence. Increasing receiver bandwidth and decreasing slice thickness combined with VAT significantly reduced the area of metal-induced artifacts. Irregular soft tissue mass, soft tissue edema, bone destruction, and fistula were significant features of periprosthetic infection, with sensitivities of 47.4-100% and specificities of 73.1-100.0%, which were confirmed based on surgical and pathological findings. Soft tissue mass was a significant feature of tumor recurrence, with 100% sensitivity, 96.0% specificity, and 97.0% consistency. The optimized VAT MRI method demonstrated a high level of diagnostic accuracy for the detection of periprosthetic infection and tumor recurrence in joint replacement patients.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27841342 PMCID: PMC5107991 DOI: 10.1038/srep36995
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Optimization sequence of MRI parameters.
| Sequence | Bandwidth (kHz) | Slice (mm) | Scanning time (min) |
|---|---|---|---|
| Routine sequence | 31.25 | 5 | 1:31 |
| Parameter optimized sequence 1 | 60.25 | 7 | 1:31 |
| Parameter optimized sequence 2 | 90.91 | 6 | 1:31 |
| Parameter optimized sequence 3 | 125 | 4 | 1:31 |
| Parameter optimized sequence 4 | 166.67 | 3 | 1:31 |
| Parameter optimized sequence 5 | 200 | 2 | 1:31 |
| Parameter optimized sequence 6 | 250 | — | 1:31 |
Figure 1Correlation of bandwidth with the artifact areas for the cobalt chromium molybdenum alloy (CCMA) and titanium alloy (TA) prostheses.
Figure 2Correlation of slice thickness with the artifact areas for the cobalt chromium molybdenum alloy (CCMA) and titanium alloy (TA) prostheses.
Figure 3Representative images of patients scanned using the optimized MRI parameters (high bandwidth [HBW] and thin slice [TS]) with or without VAT.
(A) MRI of hip joint prosthesis showing (Left) imaging with simple parameter optimizations and (Right) imaging with parameter optimizations and VAT. (B) MRI of joint prosthesis showing (Left) imaging with simple parameter optimizations and (Right) imaging with parameter optimizations and VAT. (C) Knee joint prosthesis MRI showing (Left) imaging with simple parameter optimizations and (Right) imaging with parameter optimizations and VAT.
Number and percentage of patients with (n = 19) or without (n = 67) periprosthetic infection after hip replacement who exhibited the various MRI features.
| Periprosthetic feature | Infection | No infection | χ2 | |
|---|---|---|---|---|
| Irregular soft tissue mass | 10 (52.6%) | 7 (10.4%) | 16.608 | 0.000 |
| Soft tissue edema | 19 (100%) | 18 (26.9%) | 32.298 | 0.000 |
| Hydrarthrosis | 8 (42.1%) | 16 (23.9%) | 2.444 | 0.118 |
| Bone Edema | 8 (42.1%) | 15 (22.4%) | 2.937 | 0.087 |
| Bone destruction | 9 (47.4%) | 5 (7.5%) | 17.296 | 0.000 |
| Sinus tract | 9 (47.4%) | 0 (0%) | 35.446 | 0.000 |
The tumor locations in patient with (n = 17) or without (n = 50) recurrence after joint replacement.
| Patients with tumor recurrence (n = 17) | Patients without tumor recurrence (n = 50) | ||
|---|---|---|---|
| Tumor location | |||
| Proximal femur | 7 (41.2%) | 4 (8.0%) | 0.001 |
| Proximal humerus | 5 (29.4%) | 4 (8.0%) | 0.025 |
| Distal femur | 5 (29.4%) | 31 (62.0%) | 0.020 |
| Proximal tibia | 0 (0) | 11 (22.0%) | 0.034 |
| Pathological diagnosis | |||
| Chondrosarcoma | 2 (11.8%) | 1 (2.0%) | 0.093 |
| Osteosarcoma | 14 (82.3%) | 44 (88.0%) | 0.555 |
| PNET/Ewing | 1 (5.9%) | 1 (2.0%) | 0.416 |
| Bony giant-cell tumor | 0 (0) | 1 (2.0%) | 0.057 |
| Spindle cell sarcoma | 0 (0) | 2 (4.0%) | 0.402 |
| Malignant fibrous histiocytoma | 0 (0) | 1 (2.0%) | 0.557 |
Figure 4MRI features of joint replacement patients with or without tumor recurrence.
(A) Imaging results for a 19-year-old male patient with right femoral osteosarcoma who received femoral segment resection and joint replacement, with no sign of tumor recurrence at 3 months postsurgery. (Aa) Anteroposterior X-ray showed the affected knee joint prosthesis was positioned well. The surrounding soft tissue was swollen, but no abnormal soft tissue mass was present. (Ab) Whole body bone scan showed radioactivity uptake enrichment at the affected knee joint and tibiofibula. Follow-up MRI included (Ac) coronal T1WI, (Ad) coronal T2WI, (Ae) sagittal STIR, (Af) transverse T2WI, and (Ag) STIR plain images and (Ah) transverse, (Ai) coronal, and (Aj) sagittal T1WI enhanced images. (B) Imaging results for a 33-year-old male patient following left humeral proximal osteosarcoma tumor segment resection and joint replacement. (Ba) Anteroposterior X-ray of affected shoulder joint showing well-positioned prosthesis and normal surrounding soft tissue. (Bb) Whole body bone scan showing radioactivity uptake enrichment on the distal affected humeral bone. Follow-up MRI at 3 months postsurgery included (Bc–Be) coronal T1WI, T2WI, and STIR scans, which showed fuzzy muscle structures around the prosthesis. Higher signal on the T2WI and STIR images revealed no obvious abnormal soft tissue mass around implants. (Bf) Whole body bone scan showed radioactivity uptake enrichment at the distal affected humeral bone, which was similar with the previous image. Follow-up MRI at 10 months postsurgery included (Bg–Bi) coronal T1WI, T2WI, and STIR images and transverse (Bj, upper) T2WI and (Bj, lower) STIR images, which showed increased nodular soft tissue signals in the inferior left shoulder joint that was a relatively low signal in the T1WI images, a slightly higher signal in the T2WI images, and a mixed high and low signal in the STIR images (arrow). Periprosthetic bone edema was also observed.
Number and percentage of patients with (n = 17) or without (n = 50) tumor recurrence after joint replacement who exhibited the various MRI features.
| Periprosthetic feature | No recurrence | Recurrence | χ2 | |
|---|---|---|---|---|
| Soft tissue mass | 2 (4.0%) | 17 (100%) | 57.549 | 0.000 |
| Soft tissue edema | 40 (80.0%) | 11 (64.7%) | 1.632 | 0.201 |
| Effusion | 43 (86.0%) | 2 (11.8%) | 31.701 | 0.000 |
| Bone edema | 11 (22.0%) | 3 (17.6%) | 0.143 | 0.703 |
| Bone destruction | 1 (1.5%) | 5 (29.4%) | 11.692 | 0.001 |
Consistency of MRI features for diagnosing tumor recurrence.
| Periprosthetic feature | κ-value | Consistency | |
|---|---|---|---|
| Soft tissue mass | 0.924 | 0.000 | Significant and satisfactory |
| Soft tissue edema | −0.092 | 0.201 | Without significance |
| Effusion | −0.481 | 0.000 | Without significance |
| Bone edema | 0.145 | 0.499 | Significant and unsatisfactory |
| Bone destruction | 0.342 | 0.001 | Significant and unsatisfactory |
Sensitivity, specificity, and consistency of optimized VAT MRI for diagnosing periprosthetic infection and tumor recurrence in joint replacement patients.
| Hip replacement (n = 86) | Joint replacement for cancer (n = 67) | ||||
|---|---|---|---|---|---|
| Diagnostic variable | Soft tissue mass | Soft tissue edema | Bone destruction | Fistula | Soft tissue mass |
| Sensitivity | 52.6% | 100.0% | 47.4% | 47.4% | 100.0% |
| Specificity | 89.6% | 73.1% | 92.5% | 100.0% | 96.0% |
| Consistency | 81.4% | 79.1% | 82.6% | 88.4% | 97.0% |